SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size 2/12/20 Innovate Biopharmaceuticals, Inc. 8-K:1,3 2/06/20 2:47K |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 19K 2: EX-4.1 Instrument Defining the Rights of Security Holders HTML 11K
Document |
Delaware | 27-3948465 | |||
(State
or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title
of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock $0.0001 Par Value | INNT | The Nasdaq Stock Market LLC |
Item
1.01. | Entry into a Material Definitive Agreement. |
Item 3.02. | Unregistered Sales of Equity Securities. |
Item
9.01. | Financial Statements and Exhibits. |
Innovate
Biopharmaceuticals, Inc. | ||
Date: February 12, 2020 | By: | /s/ Edward J. Sitar |
Chief
Financial Officer |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
9/18/20 | ||||
Filed on: | 2/12/20 | |||
For Period end: | 2/6/20 | |||
3/18/19 | 10-K, 424B5, 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/23 9 Meters Biopharma, Inc. 424B5 1:1.2M 3/31/21 9 Meters Biopharma, Inc. 424B5 1:1.9M 3/30/21 9 Meters Biopharma, Inc. 424B5 1:1.9M 12/11/20 9 Meters Biopharma, Inc. 424B5 1:1M 12/10/20 9 Meters Biopharma, Inc. 424B5 1:1M 10/09/20 9 Meters Biopharma, Inc. 424B5 1:1M 10/08/20 9 Meters Biopharma, Inc. S-3/A 3:1.3M 10/02/20 9 Meters Biopharma, Inc. S-3 4:1.7M 8/13/20 9 Meters Biopharma, Inc. S-8 8/13/20 3:110K 8/13/20 9 Meters Biopharma, Inc. S-8 8/13/20 3:91K |